Delivery Order SPE2DB22D3004-SPE2DB24FRY26

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,867,341 units of Meloxicam 15 mg tablets in 180-count bottles, with a ceiling value of $28,109.04. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 6, 2024. This contract is not designated as a set-aside....
This is a $1,223.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 15 mg tablet units, a medication commonly used to treat pain and inflammation. The contract has a period of performance through June 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $84,021.04 firm fixed-price contract is for the delivery of 1,000 units of the prescription drug Meloxicam 15 mg tablets. The order, which has a completion date of September 13, 2024, is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,825.47, is for the supply of Meloxicam 15 mg tablets to support military healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 15 mg meloxicam tablets. The contract has a ceiling value of $6,877.13 and a completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Meloxicam 7.5 mg tablets. The contract has a ceiling value of $3,663.43 and a completion date of December 4, 2024. It is a firm-fixed-price contract, and there was no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,697.97 firm-fixed-price contract is for the delivery of 180-count packages of the generic medication meloxicam 15 mg tablets. There is no set-aside designation for this award. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,269.10, is for the delivery of 180 tablets of the medication Meloxicam 15 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award is for the delivery of Meloxicam 15 mg tablets in 180-count bottles. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,774.69, and has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 180 tablets of meloxicam 15 mg. The contract has a firm fixed price of $6,491.16 and an ultimate completion date of September 10, 2024. The award is not associated with a set-aside program. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, such as a $999,999,999...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRY26
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $43,151.10 fixed-price contract is for the supply of 4,565,927 units of the pharmaceutical drug Meloxicam 15 mg tablet. The delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen. The contract does not have a set-aside designation and is scheduled for completion on September 25, 2024.

Generated 12/24/24, 9:35 AM